Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neumora Therapeutics, Inc.

1.28
-0.1200-8.57%
Post-market: 1.310.0300+2.34%19:56 EDT
Volume:914.58K
Turnover:1.21M
Market Cap:207.33M
PE:-0.84
High:1.43
Open:1.42
Low:1.27
Close:1.40
Loading ...

RBC Capital Sticks to Its Hold Rating for Neumora Therapeutics, Inc. (NMRA)

TIPRANKS
·
04 Mar

Neumora Therapeutics price target lowered to $18 from $30 at H.C. Wainwright

TIPRANKS
·
04 Mar

Neumora Therapeutics Earnings Call: Balancing Growth and Challenges

TIPRANKS
·
04 Mar

Strategic Adjustments and Future Prospects Drive Buy Rating for Neumora Therapeutics

TIPRANKS
·
04 Mar

Stifel Adjusts Price Target on Neumora Therapeutics to $6 From $26, Maintains Buy Rating

MT Newswires Live
·
03 Mar

Neumora Therapeutics Q4 2024 GAAP EPS $(0.37) Beats $(0.45) Estimate, Cash Balance Of $307.6M

Benzinga
·
03 Mar

Neumora Therapeutics Inc: to Prioritize Resources Allocated to Navacaprant on Koastal Program

THOMSON REUTERS
·
03 Mar

Neumora Therapeutics Inc Q4 Shr View $-0.45 -- Lseg Ibes Data

THOMSON REUTERS
·
03 Mar

Neumora Therapeutics Inc - Discontinues Phase 2 Trial for Navacaprant in Bipolar Depression

THOMSON REUTERS
·
03 Mar

Press Release: Neumora Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Dow Jones
·
03 Mar

Neumora Therapeutics, Inc. (NMRA) Gets a Buy from Mizuho Securities

TIPRANKS
·
25 Feb

Neumora Therapeutics Inc : Mizuho Cuts Target Price to $4 From $20

THOMSON REUTERS
·
25 Feb

Mizuho Securities Adjusts Neumora Therapeutics Price Target to $4 From $20, Maintains Outperform Rating

MT Newswires Live
·
24 Feb

Analysts Have Conflicting Sentiments on These Healthcare Companies: Select Medical (SEM), DENTSPLY SIRONA (XRAY) and Neumora Therapeutics, Inc. (NMRA)

TIPRANKS
·
24 Feb

3 US Penny Stocks With Market Caps Below $400M

Simply Wall St.
·
19 Feb

Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and Neumora Therapeutics, Inc. (NMRA)

TIPRANKS
·
18 Feb